US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Eledon Pharmaceuticals Inc (ELDN) ニュース

Eledon Pharmaceuticals Inc (ELDN)

3.905

0.205

( 5.54% )

更新日時： 04:57:53

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

– All 12 patients in study (100%) achieved insulin independence, producing their own insulin and no longer...

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN...

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights

100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet...

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026

NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Reported updated results from 12 patients with type 1 diabetes treated with tegoprubart following islet...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

BottomBounce

BottomBounce 1年前

Nothing to see here, just "SIDS." pic.twitter.com/FMVtXTfWEM— Died Suddenly (@DiedSuddenly_) May 8, 2025 $ELDN

Monksdream

Monksdream 1年前

Monksdream

Monksdream 2年前

ELDN, new 52=week high

PonkenPlonken

PonkenPlonken 2年前

Dear Laster, sadly I am usually inactive on individual boards because rarely someone replies. I agree with all that you said. Great things happening here. Hoping for 7$. I believe the T1D can help it further.

PonkenPlonken

PonkenPlonken 2年前

these have worked out for me.
this might fix T1D. Great work with CareDX

Laster

Does anyone seriously understand the significance of their results?
You could have had this at $3.50.
Market red and ELDN shows incredible strength.
I think it can actually break $4.50 today on a crappy day.
That must say something about the interest In this stock.
Hello? Anyone out there? Lol

Laster

Just wow is all I can say. This stock is showing lots of strength again today.
So glad I averaged down several times on Tuesday.
Wow.

Laster

Wow. ELDN at $3.95.
I bought more this morning in $3.70’s.
Just imagine where this goes when that financing closes TODAY sometime.
This news is huge for the treatment of diabetes. Unreal.
Where is everyone?
I guess it’s just me here like when I was alone on the TSSI board (from $0.60 to now $8).

ELDN. Low float. Excellent news. Great financing terms. 52 week high with no overhang.
Yet people will chase DRUG or MNPR.
I don’t mind being the first to the party. lol.

Laster

How. Surprised by the weakness here. Really thought $3.65 would be the support.
Thinking PP price $3.65 would offer support.
I guess my $4.50 target is kind of ridiculous.
Now hoping for $4.00 sooner or later.
Still think this company has really good potential.

Laster

Rug pull after you idiots see my post?
Whatever. I have my conviction.
I will wait for this to move over $4.
Then $4.50 and likely top out at $5.00.

Laster

Great news. Financing at yesterday’s close.
I got in at $3.60. Why not.
Chart showing nice flag on 15 min.
Resistance and breakout last $4.
Fingers crossed. This could run hard after lunch. JMO.

Monksdream

Monksdream 2年前

ralfito

ralfito 2年前

ELDN: Eledon Pharmaceuticals, Inc. (United States:NCM) || 3.14: -0.05 : -1.57%
Time: 2024-07-25 10:47:30 EDT
Sector/Industry: Healthcare/Biotechnology
+------------------+------------------+----------------+--------------------+
| AveVol: 215221 | Volume: 30287 | VolPct: 14.07% | Outstanding: 38.5M |
| Open: 3.23 | PrevClose: 3.19 | OpenDif: 0.04 | Float Share: 28.1M |
| High: 3.23 | Low: 3.09 | Diff: 0.14 | Insider Pct: 3.5% |
| Bid: 3.02 | Ask: 3.26 | Spread: 0.24 | Institu Pct: 30.4% |
| BidSize: 100 | AskSize: 100 | Beta: 0.91 | |
+------------------+------------------+----------------+--------------------+
+-----------------+------++----------------+-------++--------------+--------+
| Num Analysts: | 5 || Quick Ratio: | 10.09 || TrailingEps: | -1.23 |
| Recommendation: | BUY || Current Ratio: | 11.3 || ForwardEps: | -0.62 |
| TargetLow: | 7.0 || TrailingPEG | - || DebtEqRatio: | 0.38 |
| TargetHigh: | 28.0 || PEG Ratio: | 0.04 || Cash: $ | 42.9M |
| TargetMean: | 14.0 || Short Ratio: | 1.02 || Debt: $ | 284.0K |
| TargetMedian: | 10.0 || Price/Book: | 1.04 |+--------------+--------+
+-----------------+------++----------------+-------+

Monksdream

Monksdream 2年前

ralfito

ralfito 2年前

ELDN very weak today. Anyone know why?

ralfito

ralfito 2年前

ELDN still strong today. Just need a positive forward EPS.
Any thoughts?

ralfito

ralfito 2年前

ELDN: Eledon Pharmaceuticals, Inc. (United States:NCM) || 2.82: -0.02 : -0.7%
Time: 2024-06-06 13:06:56 EDT
Sector/Industry: Healthcare/Biotechnology
+------------------+------------------+-------------------------+--------------------+
| AveVol: 200319 | Volume: 43517 | VolPct: 21.72% | Outstanding: 38.5M |
| Open: 2.86 | PrevClose: 2.84 | OpenDif: 0.02 | Float Share: 30.0M |
| High: 2.87 | Low: 2.77 | Diff: 0.10 | Insider Pct: 3.5% |
| Bid: 2.80 | Ask: 2.85 | Spread: 0.05 | Institu Pct: 31.4% |
| BidSize: 100 | AskSize: 100 | Beta: 0.76 | |
+------------------+------------------+-------------------------+--------------------+
+-----------------+------++----------------+-------++--------------+--------+
| Num Analysts: | 5 || Quick Ratio: | 10.09 || TrailingEps: | -1.23 |
| Recommendation: | BUY || Current Ratio: | 11.3 || ForwardEps: | -0.62 |
| TargetLow: | 7.0 || PEG Ratio: | 0.04 || DebtEqRatio: | 0.38 |
| TargetHigh: | 28.0 || Short Ratio: | 0.68 || Cash: $ | 42.9M |
| TargetMean: | 14.0 || Price/Book: | 0.94 || Debt: $ | 284.0K |
| TargetMedian: | 10.0 |+----------------+-------++--------------+--------+
+-----------------+------+

Some Stats on ELDN

ralfito

ralfito 2年前

ELDN is doing well, but any news on the technical/bio side? Is there any progress being made in the lab?

TrendTrade2016

TrendTrade2016 2年前

TrendTrade2016

TrendTrade2016 2年前

ELDN TREND HERE IS STRONG

PonkenPlonken

PonkenPlonken 2年前

unfolding now... when news are great, biotechs return to their PM highs in the session(s after).

TrendTrade2016

TrendTrade2016 2年前

ELDN..CLOSED STRONG WHILE ALL THE POS STOCKS GOT DUMPED...THE WEEKLY WILL ALWAYS PROVE ITS MERIT!

TrendTrade2016

TrendTrade2016 2年前

ELDN bio beastly

TrendTrade2016

TrendTrade2016 2年前

ELDN HERE WE GO

TrendTrade2016

TrendTrade2016 2年前

ELGN..WEEKLY SET UP ON THIS BIO

ralfito

ralfito 2年前

Today was +270% volume, ad up almost 8% to 2.44. Ratios (quick/current) still holding near 13.

PonkenPlonken

PonkenPlonken 2年前

this one will prosper greatly. Oversubscribed offering that wasnt a sale in a VERY niche space.
Think they fund without taking a peak behind the curtains?
Maybe you need a longer time frame than 2 hours here but i think it goes to 10+

TheFinalCD

TheFinalCD 2年前

3.33-2.03 ***ITS A TRAP****

$eldn 2.22 oversubscribed turd
now red after hitting 3.33 on news, heres the 2nd PRhttps://t.co/3DcVJcaDnN(NASDAQ,development%20for%20the%20prevention%20of— THE FINAL COUNTDOWN (@THIS_TIME_X) May 7, 2024

Awl416

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement

Monksdream

Monksdream 2年前

ralfito

ralfito 2年前

Eldn stats have iproved a bit on the EPS side.:

+------------------------++------------------------++-----------------------+
¦ Num Analysts: ¦ 5 ¦¦ Quick Ratio: ¦ 13.12 ¦¦ TrailingEps: ¦ -1.64 ¦
¦ Recommendation: ¦ BUY ¦¦ Current Ratio: ¦ 14.41 ¦¦ ForwardEps: ¦ -0.78 ¦
¦ TargetLow: ¦ 7.0 ¦¦ PEG Ratio: ¦ 0.02 ¦¦ DebtEqRatio: ¦ 0.46 ¦
¦ TargetHigh: ¦ 39.0 ¦¦ Short Ratio: ¦ 0.99 ¦¦ Cash: $ ¦ 51.1M ¦
¦ TargetMean: ¦ 15.6 ¦¦ Price/Book: ¦ 0.61 ¦¦ Debt: $ ¦ 383.0K ¦
¦ TargetMedian: ¦ 10.0 ¦+------------------------++-----------------------+
+------------------------+

ralfito

ralfito 2年前

Something is up with Eldn, volume of last few days much higher than average. Still a good by IMHO.
Today is on course for another high volume day.

ralfito

ralfito 2年前

Big numbers today: 327% volume. +0.42. Anyone know why?

ralfito

ralfito 2年前

This stock is slated to improve its EPS for next year. Numbers look good.
What is holding it back?

ralfito

ralfito 2年前

ELDN: Eledon Pharmaceuticals, Inc. (United States:NCM) || 1.675: +0.015 : +0.9%
Time: 2024-04-12 10:00:07 EDT
Sector/Industry: Healthcare/Biotechnology
?------------------------??------------------------??-----------------------?
¦ Num Analysts: ¦ 5 ¦¦ Quick Ratio: ¦ 20.56 ¦¦ TrailingEps: ¦ -5.44 ¦
¦ Recommendation: ¦ BUY ¦¦ Current Ratio: ¦ 21.73 ¦¦ ForwardEps: ¦ -0.78 ¦
¦ TargetLow: ¦ 7.0 ¦¦ PEG Ratio: ¦ 0.02 ¦¦ DebtEqRatio: ¦ 0.52 ¦
¦ TargetHigh: ¦ 39.0 ¦¦ Short Ratio: ¦ 0.71 ¦¦ Cash: $ ¦ 59.6M ¦
¦ TargetMean: ¦ 15.6 ¦¦ Price/Book: ¦ 0.43 ¦¦ Debt: $ ¦ 479.0K ¦
¦ TargetMedian: ¦ 10.0 ¦?------------------------??-----------------------?
?------------------------?

TrendTrade2016

TrendTrade2016 2年前

ELDN...KIDNEY TRANSPLANT FRON A PIGS CELL....NBC ALL OVER THIS!

Monksdream

Monksdream 2年前

Monksdream

Monksdream 3年前

Eledon Pharmaceuticals

Series 2 Class A2 Mortga...

DI1F39 - Janeiro 2039

DJ Emerging Markets Cons...

Bmo Low Volatility Us Eq...

Radisson Mining Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。